# Isomorphic Labs

Alphabet's AI drug development company, accelerating drug discovery with AI

Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach. Founded on the principles of using artificial intelligence to transform drug discovery, it builds on the Nobel-winning AlphaFold system.

Canonical: https://uniquebase.ai/companies/isomorphic-labs
Stable identifier: UB-C4920
Snapshot captured: 2026-10-15T18:31:01.470Z
English updated: 2026-10-15T21:09:05.833Z

## Funding

Listed 2 records.
Latest: $2.1B (Series B), 2026-05-12.

- 2026-05-12 · $2.1B · Series B · Alphabet, CapitalG, MGX, Thrive Capital, 淡马锡 · https://x.com/AYi_AInotes/status/2054227787536289941
  > On 2026/5/12, X reported that UK AI drug discovery company Isomorphic Labs, led by Demis Hassabis, had raised USD 2.1 billion in Series B funding to shorten drug development cycles. (translated source brief)
- 2025-03-31 · $600M · Strategic · Alphabet, Google Ventures, Thrive Capital

## Valuation

Listed 2 records.

- 2026-05-12 · amount unavailable · Series B · Alphabet, CapitalG, MGX, Thrive Capital, 淡马锡 · https://x.com/AYi_AInotes/status/2054227787536289941
  > On 2026/5/12, X reported that UK AI drug discovery company Isomorphic Labs, led by Demis Hassabis, had raised USD 2.1 billion in Series B funding to shorten drug development cycles. (translated source brief)
- 2025-03-31 · amount unavailable · Strategic · Alphabet, Google Ventures, Thrive Capital

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

No published products profiles are linked yet.

## Investors

- [Alphabet](/institutions/alphabet)
- [CapitalG](/institutions/capitalg)
- [Google Ventures](/institutions/google-ventures)
- [MGX](/institutions/mgx)
- [Thrive Capital](/institutions/thrive-capital)
- [淡马锡](/institutions/danmaxi)

## Sources

- No source links are available for this profile.